Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microsomal anti-estrogen binding site (AEBS) is a high-affinity, intracellular protein complex located in the endoplasmic reticulum that binds non-steroidal anti-estrogens and histamine (Brandes et al., 1990, Biochem. Pharmacol.). It has been molecularly identified as the enzyme 3-beta-hydroxysteroid-delta-8,delta-7-isomerase (EBP), which is essential for cholesterol biosynthesis (de Medina et al., 2004, J. Biol. Chem.). Unlike the four classical G protein-coupled histamine receptors (H1-H4), AEBS mediates the effects of intracellular histamine on cell proliferation and differentiation (Silvente-Poirot et al., 2003, Mol. Pharmacol.). Drugs such as Tamoxifen and Tesmilifene (DPPE) target this site, leading to the inhibition of sterol metabolism and the induction of growth arrest in various cancer cell lines (Payre et al., 2008, Mol. Cancer Ther.). This interaction suggests that AEBS serves as a critical link between histamine signaling and the control of cellular growth, making it a significant therapeutic target in oncology (Kedjouar et al., 2004, J. Biol. Chem.). The binding of histamine to AEBS is thought to regulate the production of specific sterols that act as signaling molecules for cell differentiation (de Medina et al., 2011, Proc. Natl. Acad. Sci. USA). Research indicates that AEBS is involved in the mechanism of action of several anti-cancer agents, providing a pathway for inducing cell death independent of the estrogen receptor (Poirot et al., 2012, Biochem. Pharmacol.). Its role in cholesterol homeostasis also links it to potential metabolic and developmental disorders (Herman, 2003, Am. J. Med. Genet.).
Inhibition of the enzyme 3-beta-hydroxysteroid-delta-8,delta-7-isomerase (EBP) and modulation of intracellular histamine signaling to induce cell cycle arrest and apoptosis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microsomal anti-estrogen binding site (AEBS) (AEBS).